PMS-SOTALOL - 160 MG TABLET

Država: Kanada

Jezik: engleski

Izvor: Health Canada

Kupi sada

Preuzimanje Svojstava lijeka (SPC)
02-02-2016

Aktivni sastojci:

SOTALOL HYDROCHLORIDE

Dostupno od:

PHARMASCIENCE INC

ATC koda:

C07AA07

INN (International ime):

SOTALOL

Doziranje:

160MG

Farmaceutski oblik:

TABLET

Sastav:

SOTALOL HYDROCHLORIDE 160MG

Administracija rute:

ORAL

Jedinice u paketu:

100/500

Tip recepta:

Prescription

Područje terapije:

BETA-ADRENERGIC BLOCKING AGENTS

Proizvod sažetak:

Active ingredient group (AIG) number: 0113778001; AHFS:

Status autorizacije:

APPROVED

Datum autorizacije:

1998-07-06

Svojstava lijeka

                                _O _
PRODUCT MONOGRAPH
PMS-SOTALOL
(Sotalol Hydrochloride Tablets BP)
80 mg, 160 mg and 240 mg
ANTIARRHYTHMIC
Pharmascience Inc.
Date of Preparation:
6111 Royalmount
June 30, 1998
Montreal, Canada
Control No. 051859
H4P 2T4
Date of Revision:
November 27, 2002
Control No: 079637
•
PRODUCT MONOGRAPH
NAME OF DRUG
PMS-SOTALOL
(Sotalol Hydrochloride Tablets BP)
80 mg, 160 mg and 240 mg
THERAPEUTIC CLASSIFICATION
Antiarrhythmic
ACTION AND CLINICAL PHARMACOLOGY
pms-SOTALOL(sotalolhydrochloride)hasbothbeta-adrenoreceptoiblocking(VaughanWilliams
Class II) and cardiac action potential duration prolongation (Vaughan
Williams Class III)
antiarrhythmicproperties.pms-SOTALOLisaracemicmixtureofd-andl-sotalol.
Both i somers
have similar class III antiarrhythmic effects, while the 1-isomer is
responsible for virtually all of
thebeta-blockingactivity. Sotalol isnon-cardioselectiveand isnot
associated with partial agonist
or membrane stabilizing activity. Whereas significant beta-blockade
may occur at oral doses as
low as 25 mg, Class III effects are seen at daily doses of 160 mg and
above. The antiarrhythmic
activity of sotalol appears to be primarily due to the drug's Class
III property, based on animal
models.
Pharmacologically, in addition to its antiarrhythmic properties,
pms-SOTALOL also hi
antihypertensive and anti-anginal properties.
ELECTROPHYSIOLOGY:
in the isolated myocyte, as well as in isolated tissue preparations of
ventricular and atrial muscle
(class III activity).
In intact animals it slows heart rate, decreases AV nodal conduction
and
increases the refractory periods of atrial and ventricular muscle and
conduction tissue.
Inman,theclassII(beta-blockade)electrophysiologicaleffectsofpms-SOTALOLaremanifested
by increased sinus cycle length, decreased AV nodal conduction and
increased AV noda
refractoriness. The class III electrophysiological effects in man
include prolongation ofthe atrial
andventricularmonophasicactionpotentials,andeffectiverefractoryperiodprolongationofatrial
muscle, ventricular muscle, and atrio
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Svojstava lijeka Svojstava lijeka francuski 26-01-2016

Upozorenja za pretraživanje vezana za ovaj proizvod